Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Tail Insurance Protects Against Medical Malpractice Claims from Previous Jobs
Physicians who are resigning, retiring, switching jobs, or are terminated should consider tail insurance to cover malpractice claims brought after they’ve left their current employer
Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis
A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
A grant from the American College of Rheumatology (ACR)’s Rheumatology Research Foundation has helped Shiva Shahrara, PhD, conduct research into the molecule, IL-17, that plays a role in recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization
What’s in Store for Rheumatology in the 113th Congress?
In addition to seeking improvements to the Affordable Care Act, the American College of Rheumatology (ACR) will promote other legislative healthcare priorities including physician payment reform, patient access to treatment, and funding for medical research
A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront
Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights
ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules
Rheumatologists should develop a plan to keep in step with federal regulations
ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
- « Previous Page
- 1
- …
- 238
- 239
- 240
- 241
- 242
- …
- 300
- Next Page »